McMillan Shakespeare Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

McMillan Shakespeare şirketinin toplam hissedar öz sermayesi A$128.8M ve toplam borcu A$547.2M olup, bu da borç-öz sermaye oranını 424.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$1.3B ve A$1.2B dir. McMillan Shakespeare 'in FAVÖK'ü A$155.9M faiz karşılama oranı 6.2 dur. Şirketin A$154.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

424.7%

Borç/özkaynak oranı

AU$547.23m

Borç

Faiz karşılama oranı	6.2x
Nakit	AU$154.63m
Eşitlik	AU$128.84m
Toplam yükümlülükler	AU$1.17b
Toplam varlıklar	AU$1.30b

Son finansal sağlık güncellemeleri

Recent updates

The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing

Sep 17

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Sep 02

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

Feb 23

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

Oct 25

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

Aug 24

A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)

Jun 29

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

Jun 15

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Mar 06

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Oct 26

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Aug 31

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Jul 28

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Apr 01

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

Mar 06

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

Feb 09

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Jan 19

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

Jan 04

Is McMillan Shakespeare Limited (ASX:MMS) Trading At A 34% Discount?

Dec 20

At AU$11.83, Is McMillan Shakespeare Limited (ASX:MMS) Worth Looking At Closely?

Dec 06

Should We Be Cautious About McMillan Shakespeare Limited's (ASX:MMS) ROE Of 1.0%?

Nov 23

McMillan Shakespeare Limited (ASX:MMS) Insiders Increased Their Holdings

Sep 13

Is Now An Opportune Moment To Examine McMillan Shakespeare Limited (ASX:MMS)?

Aug 25

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MMS 'nin kısa vadeli varlıkları ( A$685.7M ) kısa vadeli yükümlülüklerini ( A$581.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: MMS şirketinin kısa vadeli varlıkları ( A$685.7M ) uzun vadeli yükümlülüklerini ( A$592.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MMS 'nin net borç/öz sermaye oranı ( 304.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: MMS şirketinin borç/öz sermaye oranı son 5 yılda 88.7% seviyesinden 424.7% seviyesine yükseldi.

Borç Kapsamı: MMS 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: MMS 'in borcuna ilişkin faiz ödemeleri EBIT ( 6.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

McMillan Shakespeare Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Recent updates

The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing

McMillan Shakespeare Limited Appoints Elizabeth Spooner as Company Secretary

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2024 earnings: EPS misses analyst expectations

Price target decreased by 7.3% to AU$19.72

Mcmillan Shakespeare Limited Announces Chief Financial Officer Appointments

Upcoming dividend of AU$0.76 per share

First half dividend of AU$0.76 announced

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

McMillan Shakespeare Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 22%

Consensus EPS estimates increase by 16%

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

Price target decreased by 7.3% to AU$18.81

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

Upcoming dividend of AU$0.66 per share at 7.0% yield

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

Mcmillan Shakespeare Limited Announces Dividend for the Six Month Ended June 30, 2023, Payable on September22, 2023

New major risk - Financial position

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired Asset Finance Aggregation business of McMillan Shakespeare Limited.

Price target increased by 7.8% to AU$17.45

A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of AU$0.58 per share at 10.0% yield

First half 2023 earnings released: EPS: AU$0.48 (vs AU$0.39 in 1H 2022)

McMillan Shakespeare Limited, Annual General Meeting, Oct 27, 2023

Independent Non-Executive Chairman recently bought AU$62k worth of stock

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$0.74 per share

McMillan Shakespeare Limited Appoints Arlene Tansey as Independent Non-Executive Director, Effective 7 November 2022

McMillan Shakespeare Limited Announces Retirement of Tim Poole From the Board of Directors, Effective 31 August 2022

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to AU$13.63

McMillan Shakespeare Limited Declares Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on November 10, 2022

Investor sentiment improved over the past week

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Price target decreased to AU$13.01

Price target increased to AU$14.29

Price target decreased to AU$13.23

Upcoming dividend of AU$0.34 per share

McMillan Shakespeare Limited, Annual General Meeting, Oct 28, 2022

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

McMillan Shakespeare Limited Declares an Interim Fully Franked Dividend, Payable on 25 March 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of AU$0.31 per share

McMillan Shakespeare Limited (ASX:MMS) acquired Plan Tracker.

Full year 2021 earnings released: EPS AU$0.79 (vs AU$0.016 in FY 2020)

Price target increased to AU$14.84

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Non-Executive Director recently sold AU$1.5m worth of stock

New 90-day low: AU$11.30

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

First half 2021 earnings released: EPS AU$0.33 (vs AU$0.42 in 1H 2020)

McMillan Shakespeare Limited (ASX:MMS) acquired remaining 50% stake in Maxxia Limited for AUD 1.8 million.

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

McMillan Shakespeare Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

Price target raised to AU$12.00

New 90-day high: AU$12.68

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?